The report is available in English with a French summary - KCE
The report is available in English with a French summary - KCE
The report is available in English with a French summary - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>KCE</strong> <strong>report</strong>s 57 Musculoskeletal & Neurological Rehabilitation 87<br />
<strong>The</strong> majority of the expenditures growth <strong>is</strong> attributed to outpatient treatment. Only<br />
2003 has a negative overall growth <strong>in</strong> expenditures, for which there <strong>is</strong> no clear<br />
explanation.<br />
Although the majority of treatment sessions <strong>is</strong> <strong>in</strong> the segment of <strong>in</strong>patients (See Figure<br />
5.20: 62%), growth <strong>in</strong> the period 2001-2004 <strong>is</strong> ma<strong>in</strong>ly expla<strong>in</strong>ed by the outpatient<br />
segment (cfr. <strong>in</strong>fra).<br />
5.1.6.6 Conclusion convention 7.71<br />
Th<strong>is</strong> specific convention can be applied <strong>in</strong> 7 Belgian rehabilitation organ<strong>is</strong>ations for a<br />
limited l<strong>is</strong>t of mostly acute neurological and musculoskeletal d<strong>is</strong>orders. Price sett<strong>in</strong>g <strong>is</strong><br />
different for each convention. <strong>The</strong> fee <strong>is</strong> higher than <strong>in</strong> the 9.50 convention and the<br />
requirements more specified. Th<strong>is</strong> convention <strong>in</strong>formally aims at patients <strong>with</strong> more<br />
complex rehabilitation needs even though the pathologies overlap <strong>with</strong> 9.50 as well as<br />
nomenclature.<br />
5.1.7 K-Nomenclature<br />
5.1.7.1 Cost model<br />
<strong>The</strong> rehabilitation nomenclature <strong>is</strong> part of the nomenclature for medical <strong>in</strong>terventions<br />
(chapter V, part 10, art.22 and 23). In the K-nomenclature there are diagnostic acts,<br />
therapeutic acts, rehabilitation acts and rehabilitation treatments (complex monod<strong>is</strong>cipl<strong>in</strong>ary<br />
or multid<strong>is</strong>cipl<strong>in</strong>ary). For the scope of th<strong>is</strong> study we only <strong>in</strong>cluded<br />
rehabilitation acts and rehabilitation treatments.<br />
<strong>The</strong> price of the sessions <strong>in</strong> the K-nomenclature <strong>is</strong> negotiated at a national level <strong>with</strong><strong>in</strong><br />
the follow<strong>in</strong>g actors:<br />
• Medicomut<br />
• Technical Medical Board (TGR / CTM)<br />
Nomenclature can be subject to <strong>in</strong>dexation if negotiated between a representation of<br />
the physicians and RIZIV/INAMI. Prices are set at a national level.<br />
K-nomenclature <strong>is</strong> applicable on <strong>in</strong> and out-patients and <strong>is</strong> subject to <strong>in</strong>dexation. Knomenclature<br />
<strong>is</strong> a “fee for service” system where one fee covers the personnel and<br />
operat<strong>in</strong>g costs of a treatment session.<br />
K-nomenclature makes a d<strong>is</strong>t<strong>in</strong>ction between “rehabilitations acts (K15/20)” and<br />
“multid<strong>is</strong>cipl<strong>in</strong>ary rehabilitation treatments (K30/60)”.<br />
• Rehabilitation acts: treatment session superv<strong>is</strong>ed by a physician<br />
special<strong>is</strong>ed <strong>in</strong> PM&R (mono-d<strong>is</strong>cipl<strong>in</strong>ary treatment allowed).<br />
• Multid<strong>is</strong>cipl<strong>in</strong>ary rehabilitation treatments: adm<strong>in</strong><strong>is</strong>tered by different<br />
therap<strong>is</strong>ts (at least two d<strong>is</strong>cipl<strong>in</strong>es, under the superv<strong>is</strong>ion of a physician<br />
special<strong>is</strong>ed <strong>in</strong> PM&R). <strong>The</strong> unit of payment <strong>is</strong> based on hourly<br />
treatment (K-30: 1 hour; K-60: 2 hours and <strong>in</strong> the futureK-45: 1,5<br />
hours).<br />
So <strong>in</strong> K30 and K60 the duration of the treatment session <strong>is</strong> def<strong>in</strong>ed as respectively one<br />
or two hours whereas K15 and K20 activities have no specified duration per session.<br />
<strong>The</strong> “new nomenclature”, <strong>in</strong> application s<strong>in</strong>ce August 2004, <strong>in</strong>troduced new<br />
rehabilitation acts and treatments (all acts and treatments l<strong>is</strong>ted <strong>in</strong> Figure 5.21 under<br />
post-2004). A limitative l<strong>is</strong>t of pathologies (Figure 5.22) for the acts concern<strong>in</strong>g<br />
multid<strong>is</strong>cipl<strong>in</strong>ary rehabilitation treatment (K30/60, more specifically codes 558810, -21, -<br />
32, -43) was also <strong>in</strong>troduced <strong>in</strong> 2004. Another important difference <strong>is</strong> that while before<br />
August 2004 a prelim<strong>in</strong>ary agreement on behalf of the mutual <strong>in</strong>surance was necessary,<br />
whereas <strong>in</strong> the new nomenclature a notification <strong>is</strong> enough, which might lower the<br />
threshold for <strong>in</strong>itiat<strong>in</strong>g multid<strong>is</strong>cipl<strong>in</strong>ary therapy. Figure 5.21 shows a general overview<br />
of the “new” K nomenclature: